Colposcopie : apport du test HPV en pratique clinique

Monsonégo, Joseph

doi:10.1016/j.gyobfe.2003.10.025

Cited by 11 publications

(2 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La généralisation de la cytologie en couche mince qui n'est utilisée en France que dans approximativement 30 % des cas ne semble pas être la solution [13]. L'engouement est actuellement à l'utilisation du test HPV [14,15] qui est très sensible et a l'avantage de ne pas être opérateur-dépendant. La méta-analyse d'Arbyn et al [16] montre leur meilleure sensibilité avec, bien entendu, une moindre spécificité qui lui fait, pour l'instant, ne pas recommander son emploi.…”

Section: Discussionunclassified

Histoire cytologique des cancers du col utérin diagnostiqués en France en 2006

Boulanger

Fauvet

Urrutiaguer

et al. 2007

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

Section: Discussionunclassified

Histoire cytologique des cancers du col utérin diagnostiqués en France en 2006

Boulanger

Fauvet

Urrutiaguer

et al. 2007

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

“…It is also indicated in the women with ASC-US who have positive results to high risk HPV (HR-HPV). When cytology is combined with HPV -DNA testing in women over 30 years old, colposcopy is indicated when HR-HPV is detected twice in a 9 months period [6] . Nevertheless, there are some other authors, such as…”

Section: Discussionmentioning

confidence: 99%

Thirty years of colposcopic studies: Validity of local destructive treatments Panama 1982-2012

Garrido¹

2014

JNEP

View full text Add to dashboard Cite

Since our intention was to verify the effectiveness of local destructive treatments which were applied to patients with oncogenic risk due to their cervical pathology, we followed 396 patients during 30 years. These treatments were applied almost immediately after the initial diagnosis was made.The evaluated parameters were the pathology type, the type of treatment, patients' evolution, and the Polymerase Chain Reaction (PCR) results. The latter is a molecular biology test which was applied to 119 cases between 2011 and 2012, this was introduced as a type of quality control and a way to confirm whether patients were actually healed or improved. With regards to the PCR results, even if the patient was considered to be cured or improved, only 5 of 119 cases were negative, and among those that resulted positive, most of them were HR-HPV, being these 31, 18, 35 and 16. The final result of the study indicates 82% of the patients were healed; 8.3% persisted with their condition; 4.8% improved; 2.8% recurred and only one case progressed, being this only 0.2%.

show abstract

Prise en charge du frottis anormal : apport de la colposcopie et du test HPV en pratique clinique

Infections À Papillomavirus

View full text Add to dashboard Cite

Colposcopie : apport du test HPV en pratique clinique

Cited by 11 publications

References 41 publications

Histoire cytologique des cancers du col utérin diagnostiqués en France en 2006

Histoire cytologique des cancers du col utérin diagnostiqués en France en 2006

Thirty years of colposcopic studies: Validity of local destructive treatments Panama 1982-2012

Prise en charge du frottis anormal : apport de la colposcopie et du test HPV en pratique clinique

Contact Info

Product

Resources

About